1. Home
  2. LWLG vs IVA Comparison

LWLG vs IVA Comparison

Compare LWLG & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$6.51

Market Cap

995.4M

Sector

Industrials

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.46

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWLG
IVA
Founded
1991
2011
Country
United States
France
Employees
34
77
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
995.4M
1.1B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
LWLG
IVA
Price
$6.51
$4.46
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$16.20
AVG Volume (30 Days)
3.0M
1.2M
Earning Date
05-08-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
N/A
EPS
N/A
N/A
Revenue
$236,855.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
147.74
N/A
52 Week Low
$1.99
$3.16
52 Week High
$18.71
$7.98

Technical Indicators

Market Signals
Indicator
LWLG
IVA
Relative Strength Index (RSI) 42.70 51.00
Support Level $6.15 $3.88
Resistance Level $7.39 $4.70
Average True Range (ATR) 0.50 0.22
MACD 0.11 0.01
Stochastic Oscillator 48.07 30.44

Price Performance

Historical Comparison
LWLG
IVA

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: